Facit BIOTECHNICA HANNOVER
(6 - 8 oktober 2009)
- Strong showing in face of tough
Growing acceptance and weight of
biotechnology in industry
Subtantial growth in number of exhibitors
and trade visitors as well as display space sold
Excellent response to conference themes of bioinformatics,
protein engineering, regenerative medicine and bio-based economy
Chalking up an increase in the number of exhibitors and trade
visitors plus the amount of display space sold, the BIOTECHNICA,
exhibition (6 to 8 October 2009) sent some important signals in
the midst of an economic crisis. “We have staged a strong
exhibition in spite of the tough economic period”, stated
Stephan Ph. Kühne, Member of the Deutsche Messe Management
Board, at the close of the tradeshow —
Europe’s biggest in the biotechnology and life
sciences sector. “Increases of more than 21 percent in exhibitor
numbers and 35 percent in terms of the amount of display space
sold, and over 11,000 trade visitors from 40 different
countries substantially exceeded our expectations”, Kühne said,
adding: “The importance of biotechnology is now firmly anchored
in people’s minds.”
650 exhibitors from 28 nations were on hand to present the latest
biotechnology products and applications for the health care, food
production, industrial and environmental protection sectors, over a
total net display area of 11,214 square meters. “BIOTECHNICA has
confirmed its position as a European marketplace for unveiling
innovations, doing business and forging new contacts. At a time when
many companies are preoccupied with overcoming short-term obstacles,
the industry has used this event to acquire a sustainable new
focus”, Kühne concluded.
Around one-third of all exhibitors were from abroad, most of them
coming from France, Switzerland,
the United States
and the United Kingdom.
This year’s event saw a record participation from the Netherlands in terms of display space and the
number of exhibitors, while
was the leading exhibitor country from the Asia-Pacific region.
Domestically, the highest number of exhibitors came from the German
states of Baden-Württemberg and North Rhine-Westphalia, followed by
Lower Saxony and Bavaria. Even Germany’s newest biotechnology
company — Enzymical, based in Thüringen, established on 16 September
2009 — turned up to showcase its products at BIOTECHNICA. Exhibitors
said their main reason for coming to the show was to generate new
leads among potential business partners and touch base with existing
customers. Biotechnologiezentrum Luckenwalde, for example, was able
to find three investors from the
United States and Korea.
International trade audience
BIOTECHNICA featured a highly international trade audience, with the
proportion of foreign visitors up by more than 25 percent. There
were also more visitors from other European countries this year. A
significant increase in attendance from North America was a gratifying development, and the
proportion of Asian visitors was up a substantial 25 percent on the
previous event. Leading countries in terms of visitor attendance
included the United Kingdom,
Netherlands, Switzerland and the United States.
Specialists from R&D and science sector represented the most sizable
attendee group, accounting for 5,500 trade visitors. Attendance from
the information and communications technology sector almost
quadrupled compared with the 2008 event. The main visitor motivation
for attending consisted of finding out about the latest innovations
on the one hand, and surveying the general market on the other.
In terms of exhibition segments, visitor attention was primarily
focused on biotechnology and pharmaceuticals/medicine. There was
also a strong interest in laboratory equipment and chemistry
Numerous conference premieres
Over 500 speakers from industry, research and government made the
conference program a genuine highlight at BIOTECHNICA. Top themes
included the use of bioinformatics to improve data analysis
capability and laboratory processes and protein engineering to treat
cancer and immune disorders.
Two conference premieres, “Bio-IT World Europe” and the “Protein
Engineering Summit — PEGS Europe”, drew a highly positive response.
Representatives of the European Commission, the German Ministry for
Education and Research
and the corporations Henkel, Süd-Chemie and Volkswagen came together
to discuss strategies for transforming Europe’s economy into a
"bio-based” economy. Two high-profile guests consisted of the
European Commission’s leading biotechnology representatives, EU
Commissioner Janez Potocnik and Maive Rute, Director
Biotechnologies. Both emphasized the continually growing importance
and acceptance of biotechnology in the general population.
Another key topic at BIOTECHNICA involved financing assistance for
startups. The new “Bio@Venture Conference” gave young companies an
opportunity to present their ideas and innovations to potential
investors. The first “Molecular Food Analytics” symposium
highlighted the contribution that new analysis technologies can make
towards detecting food allergens and genetically modified
Networking hub for industry, government and research
One of the key aims of BIOTECHNICA was to provide a networking hub
for industry, government and research. In the Biotechnology Project
Forum the German Ministry of Education and Research presented all
subsidized research projects completed in 2008. Around 120
scientists were available over the three-day show to talk with
visitors and answer their questions. The “Science to Market” forum
staged by the European Association of Pharma Biotechnology (EAPB)
was staged to promote collaboration between industry and research in
the area of pharmaceutical biotechnology. An excellent platform for
direct networking between exhibitors and visitors was provided by
Innovation Forums”, which were integrated into the exhibition and
allowed for exhibitor presentations of their companies and products.
The program of conferences, forums and workshops drew over 3,000
attendees in all.
The BIOTECHNICA partnering concept proved a successful mechanism for
bringing business partners together from all over the world.
International participants from 190 companies used this platform to
widen their circle of business contacts. The number of scheduled
business meetings was up a total of 30 percent on the previous year.
The “jobvector career day” careers platform highlighted a host of
attractive career prospects in the life sciences sector. Job-seekers
visiting the event were able to speak personally with HR managers
from leading companies.
A traditional exhibition highlight was the presentation of the
EUROPEAN BIOTECHNICA AWARD, carrying a prize purse of 100,000 euros.
This year's winner was the Swiss biopharmaceutical company
BIOTECHNICA — a global tradeshow brand
Apart from expanding itself to become Europe’s
leading networking hub for the biotech industry, BIOTECHNICA
continues to set its sights on the other major biotech regions of
the world. From 20 to 22 April 2010 the BIOTECHNICA AMERICA event
will be held in New York, followed
by the fourth BIOTECH CHINA,
staged once again in
from 2 to 4 June 2010. The next BIOTECHNICA in
will run from 5 to 7 October 2010.